Skip to main content
Premium Trial:

Request an Annual Quote

Asuragen to Manufacture RNA Control Kits for Affy-Based Tests

Premium

By Justin Petrone

Asuragen said last week that it will develop and manufacture RNA control kits for Affymetrix.

The control kits are intended for use with Asuragen-made in vitro transcription reagent kits for clinical molecular diagnostic applications that run on the Affy platform.

Austin, Tex.-based Asuragen said the kits will be configured for use with the GeneChip System 3000Dx version 2, and will be made available to companies developing and commercializing tests on the GeneChip platform. There are currently more than 20 different molecular assay tests based on the Affy platform under development by Affy and 11 partners, Asuragen said.

Asuragen inked a deal to manufacture in vitro transcription reagent kits for use with Affy's diagnostic microarray platform in July 2008 (see BAN 7/8/2008). The companies have also cooperated on other products. Asuragen began offering DiscovArray, an Affy-manufactured chip for microRNA expression profiling, in 2007 (see BAN 8/7/2007).

Financial details of the new agreement were not discussed.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.